Folate-targeting annonaceous acetogenins nanosuspensions: Significantly enhanced antitumor efficacy in hela tumor-bearing mice

49Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Annonaceous acetogenins (ACGs) are one of the most active constituents isolated from Annona species with potent antitumor activity. However, the poor solubility and severe side effect greatly limit their use in clinic. In this study, folic acid (FA) modified annonaceous acetogenins nanosuspensions (FA-PEG-ACGs-NSps) had been successfully prepared using DSPE-PEG-FA and soybean lecithin (SPC) as stabilizers. The resultant FA-PEG-ACGs-NSps had a mean particle size of 119.7 nm, a zeta potential of –23.0 mV and a high drug payload of 49.68%. The obtained ACGs-NSps had a good stability in various physiological media, and showed sustained drug release. Compared to common ACGs nanoparticles (PEG-ACGs-NSps), FA-PEG-ACGs-NSps showed significantly enhanced in vitro cytotoxicity against folate receptor-positive HeLa cell lines (IC50, 0.483 lg/mL vs. 0.915 lg/mL, p

Cite

CITATION STYLE

APA

Li, H., Li, Y., Ao, H., Bi, D., Han, M., Guo, Y., & Wang, X. (2018). Folate-targeting annonaceous acetogenins nanosuspensions: Significantly enhanced antitumor efficacy in hela tumor-bearing mice. Drug Delivery, 25(1), 880–887. https://doi.org/10.1080/10717544.2018.1455761

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free